7 studies found for:    SMAD3
Show Display Options
Rank Status Study
1 Recruiting First in Human Dose Escalation Study of TEW-7197 in Subjects With Advanced Stage Solid Tumors
Condition: Advanced Stage Solid Tumors
Intervention: Drug: TEW-7197
2 Not yet recruiting High-Dose Radiation Therapy Versus Standard Care in Treating Patients With Pancreatic Cancer That Cannot Be Removed By Surgery
Conditions: Acinar Cell Adenocarcinoma of the Pancreas;   Duct Cell Adenocarcinoma of the Pancreas;   Stage III Pancreatic Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: oxaliplatin;   Drug: irinotecan hydrochloride;   Drug: leucovorin calcium;   Drug: fluorouracil;   Radiation: intensity-modulated radiation therapy;   Radiation: 3-dimensional conformal radiation therapy;   Drug: capecitabine;   Other: laboratory biomarker analysis
3 Active, not recruiting Efficacy of a Simplified Modified Atkins Diet in Children With Refractory Epilepsy
Condition: Refractory Epilepsy
Interventions: Other: Simplified Modified Atkins Diet;   Drug: Antiepileptic drugs alone
4 Recruiting Stem Cell Recruitment in Osteoporosis Therapy
Condition: Low Bone Density
Interventions: Drug: Teriparatide;   Drug: Alendronate;   Dietary Supplement: calcium and vitamin D
5 Completed Efficacy and Safety Study of p144 to Treat Skin Fibrosis in Systemic Sclerosis
Condition: Skin Fibrosis
Interventions: Drug: P144;   Drug: placebo
6 Not yet recruiting Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer
Condition: Borderline Resectable Pancreatic Cancer
Interventions: Drug: gemcitabine/nab-paclitaxel;   Drug: mFOLFIRINOX
7 Completed Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study
Condition: Skin Fibrosis
Intervention: Drug: P144 cream

Indicates status has not been verified in more than two years